ReviewInternational journal of molecular sciences2025
Next-Level Prediction of Structural Progression in Knee Osteoarthritis: A Perspective.
Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- HIF-PH Inhibitor Promotes Stabilization of HIF-1α via Inhibition of Its Degradation and Exerts Chondroprotective Effects in a Rat Osteoarthritis Model.International journal of molecular sciences · 2026Article
- Effects of thrombospondin-1 (THBS1) and toll-like receptor 4 (TLR-4) levels in the serum and synovial fluid of patients with knee osteoarthritis.Journal of medical biochemistry · 2026Article
- Explainable machine learning identifies knee morphology thresholds for arthroscopic medial meniscus posterior root tear: a retrospective cohort study.Frontiers in medicine · 2026Article
- Advances in molecular imaging for osteoarthritis.Connective tissue research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Osteoarthritis (OA) is a prevalent and disabling chronic disease, with knee OA being the most common form, affecting approximately 73% of individuals over 55 years. Traditional clinical assessments often fail to predict knee structural progression accurately, highlighting the need for improved prognostic methods. This perspective explores the complexity of stratifying knee OA patients based on rapid structural progression. It underscores the importance of such early identification to enable timely and personalized intervention and optimize disease-modifying OA drug clinical trial design, as many trial participants show minimal progression, complicating the assessment of treatment efficacy. We highlight the potential of machine learning (ML) and deep learning (DL) in overcoming this prognostic challenge, as these methodologies enhance classification/stratification capabilities by leveraging multidimensional data and capturing the intricate relationships between diverse features. These include panels of biochemical markers and imaging markers, such as those from magnetic resonance imaging (MRI), as integrating MRI data into ML/DL prognostic models enhances such prediction performance. These automated ML/DL models will offer a transformative approach to stratifying knee OA patients and represent a paradigm shift in disease management. Ultimately, ML/DL applications will not only improve patient outcomes but will also promote innovation in OA research, clinical practice, and therapeutics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.